GARRITY THOMAS J

CIK 00012750121 companyEWING, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001275012

Recent Transactions

50 trades

Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−80,318→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−58,246→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−48,542→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−76,548→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Common Stock
2022-05-24$5.60/sh−224,406→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−46,729→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−99,395→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Stock Option (right to buy)
2022-05-24−61,930→ 0 total
Disposition to Issuer
ANTARES PHARMA, INC.
Common Stock
2022-05-24$5.60/sh−25,452→ 0 total
Award
ANTARES PHARMA, INC.
Common Stock
2021-06-10$4.42/sh+25,452→ 249,858 total
Award
ANTARES PHARMA, INC.
Stock Option (right to buy)
2021-06-10+48,542→ 48,542 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2021-03-11−50,000→ 0 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2021-03-11$1.12/sh+50,000→ 274,406 total
Sale
ANTARES PHARMA, INC.
Common Stock
2021-03-11$4.28/sh−50,000→ 224,406 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2021-02-11$1.12/sh+50,000→ 274,406 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2021-02-11−50,000→ 0 total
Sale
ANTARES PHARMA, INC.
Common Stock
2021-02-11$4.62/sh−50,000→ 224,406 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2021-01-11−20,000→ 0 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2021-01-11−50,000→ 0 total
Sale
ANTARES PHARMA, INC.
Common Stock
2021-01-11$4.05/sh−50,000→ 224,406 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2021-01-11$2.24/sh+20,000→ 244,406 total
Sale
ANTARES PHARMA, INC.
Common Stock
2021-01-11$4.07/sh−20,000→ 224,406 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2021-01-11$1.12/sh+50,000→ 274,406 total
Award
ANTARES PHARMA, INC.
Stock Option (right to buy)
2020-06-11+58,246→ 58,246 total
Award
ANTARES PHARMA, INC.
Common Stock
2020-06-11$2.73/sh+30,220→ 224,406 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2019-12-09$1.66/sh+40,000→ 234,186 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2019-12-09$1.60/sh+40,000→ 234,186 total
Sale
ANTARES PHARMA, INC.
Common Stock
2019-12-09$4.58/sh−40,000→ 194,186 total
Sale
ANTARES PHARMA, INC.
Common Stock
2019-12-09$4.58/sh−40,000→ 194,186 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2019-12-09−40,000→ 0 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2019-12-09−40,000→ 0 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2019-11-01−10,000→ 0 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2019-11-01$1.10/sh+10,000→ 194,186 total
Award
ANTARES PHARMA, INC.
Common Stock
2019-06-13$2.92/sh+23,973→ 184,186 total
Award
ANTARES PHARMA, INC.
Stock Option (right to buy)
2019-06-13+46,729→ 46,729 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2019-05-01−30,000→ 0 total
Sale
ANTARES PHARMA, INC.
Common Stock
2019-05-01$2.67/sh−30,000→ 160,213 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2019-05-01$0.53/sh+30,000→ 190,213 total
Award
ANTARES PHARMA, INC.
Stock Option (right to buy)
2018-06-08+76,548→ 76,548 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2017-10-03$0.85/sh+30,000→ 190,213 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2017-10-03−30,000→ 0 total
Sale
ANTARES PHARMA, INC.
Common Stock
2017-10-03$3.50/sh−30,000→ 160,213 total
Award
ANTARES PHARMA, INC.
Stock Option (right to buy)
2017-06-07+80,318→ 80,318 total
Exercise/Conversion
ANTARES PHARMA, INC.
Stock Option (right to buy)
2017-03-31−30,000→ 0 total
Exercise/Conversion
ANTARES PHARMA, INC.
Common Stock
2017-03-31$1.65/sh+30,000→ 190,213 total
Sale
ANTARES PHARMA, INC.
Common Stock
2017-03-31$2.91/sh−30,000→ 160,213 total
Award
ANTARES PHARMA, INC.
Stock Option (right to buy)
2016-06-02+150,000→ 150,000 total
Purchase
ANTARES PHARMA, INC.
Common Stock
2016-03-18$0.72/sh+30,000→ 160,213 total
Award
ANTARES PHARMA, INC.
Stock option (right to buy)
2015-05-28+99,395→ 99,395 total
Purchase
ANTARES PHARMA, INC.
Common Stock
2014-08-11$1.98/sh+5,000→ 130,213 total

Companies

ANTARES PHARMA, INC.
Director

Recent Filings

Address

C/O ANTARES PHARMA INC 250 PHILLIPS BLVD, SUITE 290

EWING, NJ, 08618

View on SEC.gov